Lymphatic Diseases: Clinical Trials

19 trials for Lymphatic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 terminated. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Terminated 19

Follow Lymphatic Diseases: new trials by email Literature Review of Lymphatic Diseases trials Research Report on Lymphatic Diseases

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Levofloxacin, Placebo - Neutropenic Fever, Acute Lymphoblastic Leukemia
Phase 4TerminatedGadjah Mada University492026-01-012026-10-01
Use of CXCL9 as a Biomarker of Acthar Efficacy
Acthar gel - Sarcoidosis
Phase 4TerminatedUniversity of California, San Francisco22022-11-032026-04-30
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Flumatinib, Imatinib - Acute Leukemia
Phase 4TerminatedInstitute of Hematology & Blood Diseases Hospital, China392021-09-162025-05-01
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
Blinatumomab, Current Wearable Heatlth Monitoring System (CWHMS) - B-precursor Acute Lymphoblastic Leukemia
Phase 4TerminatedAmgen102021-08-262025-05-18
Hydroxychloroquine in ANCA Vasculitis Evaluation
Hydroxychloroquine, Placebo - ANCA Associated Vasculitis, Microscopic Polyangiitis
Phase 4TerminatedGuy's and St Thomas' NHS Foundation Trust432020-12-172026-04-29
Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain
Fentanyl, Fentanyl and Ketamine, Ketamine - Pain, Acute
Phase 4TerminatedMercy Health Ohio62019-11-182020-09-11
N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia
N-Acetylcysteine, Placebo - Lymphoblastic Leukemia, Acute, Childhood
Phase 4TerminatedTeny Tjitra Sari162019-08-292022-11-09
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
Ketamine 100 MG/ML, Midazolam 5 MG/ML - Anxiety, Pediatric ALL
Phase 4TerminatedBrooke Army Medical Center102016-05-012023-04-25
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
sofosbuvir/ledipasvir, sofosbuvir, Ribavirin - Liver Disease
Phase 4TerminatedUniversity of Texas Southwestern Medical Center12016-02-252019-01-08
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
Collection of blood samples - B Acute Lymphoblastic Leukemia, Leukemia Relapse
Phase 4TerminatedUniversity Hospital, Angers1192016-01-012022-10-03
Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Methotrexate, Interferon Alfa-2b - Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides
Phase 4TerminatedPolish Lymphoma Research Group1002014-06-012022-01-13
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Aprepitant, Placebo - Sezary Syndrome, Pruritus
Phase 4TerminatedVanderbilt University Medical Center72012-02-012017-05-10
A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status
Cyclophosphamide, Fludarabine, Rituximab - Lymphocytic Leukemia, Chronic
Phase 4TerminatedHoffmann-La Roche892011-06-172018-03-20
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status
Chlorambucil, Cyclophosphamide, Fludarabine - Lymphocytic Leukemia, Chronic
Phase 4TerminatedHoffmann-La Roche262011-04-272019-03-14
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
Ferric carboxymaltose - Iron-Deficiency Anemia
Phase 4TerminatedVifor Pharma32010-03-012022-05-09
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
CryoSpray Ablation - Lung Diseases, Obstructive, Sarcoidosis
Phase 4TerminatedCSA Medical, Inc.52008-10-012015-08-18
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
PEG-interferon alfa-2b, Interferon alfa-2b, Valproic Acid - Lymphoma, Precancerous/Nonmalignant Condition
Phase 4TerminatedUniversity of Miami132007-11-012018-04-17
Use of Thalidomide in Chronic Uveitis
Thalidomide - Uveitis
Phase 4TerminatedUniversity of Cincinnati152004-01-012007-12-06
PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides
PUVA (8MOP + UVA) + IFN, PUVA (8-MOP + UVA) - Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Phase 4TerminatedMadrilenian Group of Cutaneous Lymphomas542000-01-012008-03-07

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Sarcoidosis (3)  ·  Granulomatosis with Polyangiitis (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Mycosis Fungoides (2)  ·  Acute Pain (1)  ·  Anemia (1)  ·  Anemia, Iron-Deficiency (1)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Anxiety Disorders (1)  ·  Burkitt Lymphoma (1)  ·  Churg-Strauss Syndrome (1)  ·  Febrile Neutropenia (1)  ·  HTLV-I Infections (1)  ·  Hepatitis C (1)

Broader conditions

Hemic and Lymphatic Diseases (19)  ·  Immune System Diseases (19)  ·  Lymphoproliferative Disorders (18)  ·  Immunoproliferative Disorders (15)  ·  Neoplasms (14)  ·  Neoplasms by Histologic Type (14)  ·  Hematologic Diseases (9)  ·  Leukemia, Lymphoid (8)  ·  Leukemia (7)  ·  Lymphoma (6)  ·  Lymphoma, Non-Hodgkin (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Infections (4)  ·  Hypersensitivity (3)

Interventions

Cyclophosphamide (2)  ·  Interferon alpha-2 (2)  ·  Ketamine (2)  ·  Rituximab (2)  ·  fludarabine (2)  ·  Acetylcysteine (1)  ·  Adrenocorticotropic Hormone (1)  ·  Aprepitant (1)  ·  Chlorambucil (1)  ·  Clorazepate Dipotassium (1)  ·  Cryoelectron Microscopy (1)  ·  Cryosurgery (1)  ·  Cryotherapy (1)  ·  Fentanyl (1)  ·  Hydroxychloroquine (1)

Sponsors

Hoffmann-La Roche (2)  ·  Amgen (1)  ·  Brooke Army Medical Center (1)  ·  CSA Medical, Inc. (1)  ·  Gadjah Mada University (1)  ·  Guy's and St Thomas' NHS Foundation Trust (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Madrilenian Group of Cutaneous Lymphomas (1)  ·  Mercy Health Ohio (1)  ·  Polish Lymphoma Research Group (1)  ·  Teny Tjitra Sari (1)  ·  University Hospital, Angers (1)  ·  University of California, San Francisco (1)  ·  University of Cincinnati (1)  ·  University of Miami (1)

Countries

United States (9)  ·  France (2)  ·  Indonesia (2)  ·  Russia (2)  ·  China (1)  ·  Greece (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

David D'Cruz (1)  ·  David Gemmel (1)  ·  Ewa Chmielowska, MD, PhD (1)  ·  Idha Yulandari, M.D. Pediatric (1)  ·  Juan Carlos Ramos, MD (1)  ·  Katodritou Eirini, MD (1)  ·  Laura Koth, MD (1)  ·  Mamta K. Jain, MD (1)  ·  Michael Machuzak, M.D. (1)

Results publications

PMID 32632956, PMID 30140912, PMID 30208456, PMID 33041718, PMID 37024906

NIH funding

2018 (1), P01CA128115 (1)